-
1
-
-
33644798329
-
Childhood acute lymphoblastic leukaemia and relapse
-
Gaynon PS. Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol. 2005;131: 579-587.
-
(2005)
Br J Haematol
, vol.131
, pp. 579-587
-
-
Gaynon, P.S.1
-
2
-
-
30444437486
-
Treatment of acute lymphoblastic leukemia
-
Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166-178.
-
(2006)
N Engl J Med
, vol.354
, pp. 166-178
-
-
Pui, C.H.1
Evans, W.E.2
-
3
-
-
0029118138
-
Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia
-
Gajjar A, Ribeiro R, Hancock ML, et al. Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. Blood. 1995;86:1292-1295.
-
(1995)
Blood
, vol.86
, pp. 1292-1295
-
-
Gajjar, A.1
Ribeiro, R.2
Hancock, M.L.3
-
4
-
-
0030720796
-
Early response to therapy and outcome in childhood acute lymphoblastic leukemia: A review
-
Gaynon PS, Desai AA, Bostrom BC, et al. Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review. Cancer. 1997;80:1717-1726.
-
(1997)
Cancer
, vol.80
, pp. 1717-1726
-
-
Gaynon, P.S.1
Desai, A.A.2
Bostrom, B.C.3
-
5
-
-
0028152851
-
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: Results and conclusions of the multicenter trial ALL-BFM 86
-
Reiter A, Schrappe M, Ludwig WD, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: results and conclusions of the multicenter trial ALL-BFM 86. Blood. 1994;84:3122-3133.
-
(1994)
Blood
, vol.84
, pp. 3122-3133
-
-
Reiter, A.1
Schrappe, M.2
Ludwig, W.D.3
-
6
-
-
32044451740
-
Understanding the clinical implications of minimal residual disease in childhood leukemia
-
Mandrell BN, Pritchard M. Understanding the clinical implications of minimal residual disease in childhood leukemia. J Pediatr Oncol Nurs. 2006; 23:38-44.
-
(2006)
J Pediatr Oncol Nurs
, vol.23
, pp. 38-44
-
-
Mandrell, B.N.1
Pritchard, M.2
-
7
-
-
0033569406
-
Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
-
Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286:531-537.
-
(1999)
Science
, vol.286
, pp. 531-537
-
-
Golub, T.R.1
Slonim, D.K.2
Tamayo, P.3
-
8
-
-
3543054544
-
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment
-
Holleman A, Cheok MH, den Boer ML, et al. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med. 2004;351:533-542.
-
(2004)
N Engl J Med
, vol.351
, pp. 533-542
-
-
Holleman, A.1
Cheok, M.H.2
den Boer, M.L.3
-
9
-
-
30444446961
-
The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia
-
Holleman A, den Boer ML, de Menezes RX, et al. The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood. 2006;107:769-776.
-
(2006)
Blood
, vol.107
, pp. 769-776
-
-
Holleman, A.1
den Boer, M.L.2
de Menezes, R.X.3
-
10
-
-
20244377046
-
Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia
-
Lugthart S, Cheok MH, den Boer ML, et al. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell. 2005;7:375-386.
-
(2005)
Cancer Cell
, vol.7
, pp. 375-386
-
-
Lugthart, S.1
Cheok, M.H.2
den Boer, M.L.3
-
11
-
-
0141993002
-
Classification of pediatric acute lymphoblastic leukemia by gene expression profiling
-
Ross ME, Zhou X, Song G, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood. 2003;102:2951-2959.
-
(2003)
Blood
, vol.102
, pp. 2951-2959
-
-
Ross, M.E.1
Zhou, X.2
Song, G.3
-
12
-
-
19044399684
-
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
-
Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002; 1:133-143.
-
(2002)
Cancer Cell
, vol.1
, pp. 133-143
-
-
Yeoh, E.J.1
Ross, M.E.2
Shurtleff, S.A.3
-
13
-
-
33746649033
-
Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: Prognostic significance of CASP8AP2
-
Flotho C, Coustan-Smith E, Pei D, et al. Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2. Blood. 2006;108: 1050-1057.
-
(2006)
Blood
, vol.108
, pp. 1050-1057
-
-
Flotho, C.1
Coustan-Smith, E.2
Pei, D.3
-
14
-
-
34548013784
-
A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia
-
Flotho C, Coustan-Smith E, Pei D, et al. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood. 2007;110:1271-1277.
-
(2007)
Blood
, vol.110
, pp. 1271-1277
-
-
Flotho, C.1
Coustan-Smith, E.2
Pei, D.3
-
15
-
-
2642528031
-
DNA damage-induced activation of ATM and ATM-dependent signaling pathways
-
Kurz EU, Lees-Miller SP. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst). 2004;3:889-900.
-
(2004)
DNA Repair (Amst)
, vol.3
, pp. 889-900
-
-
Kurz, E.U.1
Lees-Miller, S.P.2
-
16
-
-
9144247813
-
Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses
-
Stankovic T, Hubank M, Cronin D, et al. Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses. Blood. 2004;103:291-300.
-
(2004)
Blood
, vol.103
, pp. 291-300
-
-
Stankovic, T.1
Hubank, M.2
Cronin, D.3
-
17
-
-
3242885155
-
The switch from survival responses to apoptosis after chromosomal breaks
-
Bree RT, Neary C, Samali A, Lowndes NF. The switch from survival responses to apoptosis after chromosomal breaks. DNA Repair (Amst). 2004; 3:989-995.
-
(2004)
DNA Repair (Amst)
, vol.3
, pp. 989-995
-
-
Bree, R.T.1
Neary, C.2
Samali, A.3
Lowndes, N.F.4
-
18
-
-
4444380594
-
Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-kappaB survival pathway signaling
-
Weston VJ, Austen B, Wei W, et al. Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-kappaB survival pathway signaling. Blood. 2004;104:1465-1473.
-
(2004)
Blood
, vol.104
, pp. 1465-1473
-
-
Weston, V.J.1
Austen, B.2
Wei, W.3
-
19
-
-
27644450586
-
Mutations in the ATM gene lead to impaired overall and treatmentfree survival that is independent of IGVH mutation status in patients with B-CLL
-
Austen B, Powell JE, Alvi A, et al. Mutations in the ATM gene lead to impaired overall and treatmentfree survival that is independent of IGVH mutation status in patients with B-CLL. Blood. 2005; 106:3175-3182.
-
(2005)
Blood
, vol.106
, pp. 3175-3182
-
-
Austen, B.1
Powell, J.E.2
Alvi, A.3
-
20
-
-
36849045647
-
Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion
-
Austen B, Skowronska A, Baker C, et al. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. J Clin Oncol. 2007;25:5448-5457.
-
(2007)
J Clin Oncol
, vol.25
, pp. 5448-5457
-
-
Austen, B.1
Skowronska, A.2
Baker, C.3
-
21
-
-
0347184138
-
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
-
Coustan-Smith E, Behm FG, Sanchez J, et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet. 1998;351:550-554.
-
(1998)
Lancet
, vol.351
, pp. 550-554
-
-
Coustan-Smith, E.1
Behm, F.G.2
Sanchez, J.3
-
22
-
-
0032400846
-
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia
-
Knechtli CJ, Goulden NJ, Hancock JP, et al. Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. Blood. 1998;92:4072-4079.
-
(1998)
Blood
, vol.92
, pp. 4072-4079
-
-
Knechtli, C.J.1
Goulden, N.J.2
Hancock, J.P.3
-
23
-
-
0036096157
-
Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage
-
Stankovic T, Stewart GS, Fegan C, et al. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage. Blood. 2002 99:300-309.
-
(2002)
Blood
, vol.99
, pp. 300-309
-
-
Stankovic, T.1
Stewart, G.S.2
Fegan, C.3
-
24
-
-
36749029369
-
RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling
-
Stewart GS, Stankovic T, Byrd PJ, et al. RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling. Proc Natl Acad Sci U S A. 2007;104:16910-16915.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 16910-16915
-
-
Stewart, G.S.1
Stankovic, T.2
Byrd, P.J.3
-
25
-
-
0037316303
-
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
-
Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185-193.
-
(2003)
Bioinformatics
, vol.19
, pp. 185-193
-
-
Bolstad, B.M.1
Irizarry, R.A.2
Astrand, M.3
Speed, T.P.4
-
26
-
-
12344280017
-
Summaries of Affymetrix GeneChip probe level data
-
Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31:e15.
-
(2003)
Nucleic Acids Res
, vol.31
-
-
Irizarry, R.A.1
Bolstad, B.M.2
Collin, F.3
Cope, L.M.4
Hobbs, B.5
Speed, T.P.6
-
27
-
-
0242287052
-
Statistical methods for identifying differentially expressed genes in DNA microarrays
-
Storey JD, Tibshirani R. Statistical methods for identifying differentially expressed genes in DNA microarrays. Methods Mol Biol. 2003;224:149-157.
-
(2003)
Methods Mol Biol
, vol.224
, pp. 149-157
-
-
Storey, J.D.1
Tibshirani, R.2
-
28
-
-
0035942271
-
Significance analysis of microarrays applied to the ionizing radiation response
-
Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98:5116-5121.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 5116-5121
-
-
Tusher, V.G.1
Tibshirani, R.2
Chu, G.3
-
29
-
-
84870532154
-
-
Available at, Accessed October 21, 2008
-
National Center for Biotechnology Information. Gene Expression Omnibus database. Available at http://www.ncbi.nlm.nih.gov/geo/. Accessed October 21, 2008.
-
Gene Expression Omnibus database
-
-
-
30
-
-
27344435774
-
Gene set enrichment analysis: A knowledgebased approach for interpreting genome-wide expression profiles
-
Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledgebased approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545-15550.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 15545-15550
-
-
Subramanian, A.1
Tamayo, P.2
Mootha, V.K.3
-
31
-
-
84868909236
-
-
Broad Institute of MIT and Harvard, Database.Available at, Accessed January 10, 2007
-
Broad Institute of MIT and Harvard. Molecular Signatures Database.Available at http://www. broad.mit.edu/gsea/software/software-index. html. Accessed January 10, 2007.
-
Molecular Signatures
-
-
-
32
-
-
0032919364
-
KEGG: Kyoto Encyclopedia of Genes and Genomes
-
Ogata H, Goto S, Sato K, et al. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 1999;27:29-34.
-
(1999)
Nucleic Acids Res
, vol.27
, pp. 29-34
-
-
Ogata, H.1
Goto, S.2
Sato, K.3
-
33
-
-
34147177060
-
-
Park MY, Hastie T, Tibshirani R. Averaged gene expressions for regression. Biostatistics. 2007;8: 212-227.tial of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev. 2002;54:375-429.
-
Park MY, Hastie T, Tibshirani R. Averaged gene expressions for regression. Biostatistics. 2007;8: 212-227.tial of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev. 2002;54:375-429.
-
-
-
-
36
-
-
33750412872
-
Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: Implications for cancer therapy
-
Henson ES, Gibson SB. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal. 2006;18:2089-2097.
-
(2006)
Cell Signal
, vol.18
, pp. 2089-2097
-
-
Henson, E.S.1
Gibson, S.B.2
-
38
-
-
33746840153
-
IGF-I mediated survival pathways in normal and malignant cells
-
Kurmasheva RT, Houghton PJ. IGF-I mediated survival pathways in normal and malignant cells. Biochim Biophys Acta. 2006;1766:1-22.
-
(2006)
Biochim Biophys Acta
, vol.1766
, pp. 1-22
-
-
Kurmasheva, R.T.1
Houghton, P.J.2
-
39
-
-
34247617182
-
Sphingosine-1-phosphate lyase in immunity and cancer: Silencing the siren
-
Bandhuvula P, Saba JD. Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren. Trends Mol Med. 2007;13:210-217.
-
(2007)
Trends Mol Med
, vol.13
, pp. 210-217
-
-
Bandhuvula, P.1
Saba, J.D.2
-
40
-
-
13544259968
-
B cell selection and susceptibility to autoimmunity
-
Grimaldi CM, Hicks R, Diamond B. B cell selection and susceptibility to autoimmunity. J Immunol. 2005;174:1775-1781.
-
(2005)
J Immunol
, vol.174
, pp. 1775-1781
-
-
Grimaldi, C.M.1
Hicks, R.2
Diamond, B.3
-
41
-
-
33746466098
-
Mitochondrial mutations in cancer
-
Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene. 2006;25:4647-4662.
-
(2006)
Oncogene
, vol.25
, pp. 4647-4662
-
-
Brandon, M.1
Baldi, P.2
Wallace, D.C.3
-
42
-
-
0035859956
-
p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD
-
Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci U S A. 2001; 98:9666-9670.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 9666-9670
-
-
Harada, H.1
Andersen, J.S.2
Mann, M.3
Terada, N.4
Korsmeyer, S.J.5
-
43
-
-
1242285048
-
Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias
-
Zhao S, Konopleva M, Cabreira-Hansen M, et al. Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias. Leukemia. 2004;18:267-275.
-
(2004)
Leukemia
, vol.18
, pp. 267-275
-
-
Zhao, S.1
Konopleva, M.2
Cabreira-Hansen, M.3
-
44
-
-
34547114987
-
Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation
-
Kao GD, Jiang Z, Fernandes AM, Gupta AK, Maity A. Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation. J Biol Chem. 2007;282:21206-212.
-
(2007)
J Biol Chem
, vol.282
, pp. 21206-21212
-
-
Kao, G.D.1
Jiang, Z.2
Fernandes, A.M.3
Gupta, A.K.4
Maity, A.5
-
45
-
-
24744452428
-
Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines
-
Kim IA, Bae SS, Fernandes A, et al. Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines. Cancer Res. 2005;65: 7902-7910.
-
(2005)
Cancer Res
, vol.65
, pp. 7902-7910
-
-
Kim, I.A.1
Bae, S.S.2
Fernandes, A.3
-
46
-
-
0042632901
-
Pathways of DNA double-strand break repair during the mammalian cell cycle
-
Rothkamm K, Krüger I, Thompson LH, Löbrich M. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol. 2003; 23:5706-5715.
-
(2003)
Mol Cell Biol
, vol.23
, pp. 5706-5715
-
-
Rothkamm, K.1
Krüger, I.2
Thompson, L.H.3
Löbrich, M.4
-
47
-
-
33646753793
-
Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia
-
Graham DK, Salzberg DB, Kurtzberg J, et al. Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia. Clin Cancer Res. 2006;12:2662-2669.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 2662-2669
-
-
Graham, D.K.1
Salzberg, D.B.2
Kurtzberg, J.3
-
48
-
-
33749836690
-
Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase
-
Keating AK, Salzberg DB, Sather S, et al. Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase. Oncogene. 2006;25:6092-6100.
-
(2006)
Oncogene
, vol.25
, pp. 6092-6100
-
-
Keating, A.K.1
Salzberg, D.B.2
Sather, S.3
-
49
-
-
33644803035
-
The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: Implications for mechanisms of therapy failure
-
Beesley AH, Cummings AJ, Freitas JR, et al. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure. Br J Haematol. 2005;131:447-456.
-
(2005)
Br J Haematol
, vol.131
, pp. 447-456
-
-
Beesley, A.H.1
Cummings, A.J.2
Freitas, J.R.3
-
50
-
-
33745940511
-
Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: A Children's Oncology Group study
-
Bhojwani D, Kang H, Moskowitz NP, et al. Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 2006;108:711-717.
-
(2006)
Blood
, vol.108
, pp. 711-717
-
-
Bhojwani, D.1
Kang, H.2
Moskowitz, N.P.3
-
51
-
-
33748053012
-
Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia
-
Kirschner-Schwabe R, Lottaz C, Todling J, et al. Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia. Clin Cancer Res. 2006;12:4553-4561.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 4553-4561
-
-
Kirschner-Schwabe, R.1
Lottaz, C.2
Todling, J.3
-
52
-
-
0038103843
-
DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: Choice of technique and purification influence the identification of potential diagnostic markers
-
Staal FJ, van der Burg M, Wessels LF, et al. DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers. Leukemia. 2003;17:1324-1332.
-
(2003)
Leukemia
, vol.17
, pp. 1324-1332
-
-
Staal, F.J.1
van der Burg, M.2
Wessels, L.F.3
-
53
-
-
45149121372
-
The novel Akt inhibitor, perifosine, induces caspasedependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism
-
Chiarini F, Del Sole M, Mongiorgi S, et al. The novel Akt inhibitor, perifosine, induces caspasedependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. Leukemia. 2008;22:1106-1116.
-
(2008)
Leukemia
, vol.22
, pp. 1106-1116
-
-
Chiarini, F.1
Del Sole, M.2
Mongiorgi, S.3
-
54
-
-
34548138930
-
Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway
-
Doepfner KT, Spertini O, Arcaro A. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway. Leukemia. 2007;21:1921-1930.
-
(2007)
Leukemia
, vol.21
, pp. 1921-1930
-
-
Doepfner, K.T.1
Spertini, O.2
Arcaro, A.3
-
55
-
-
34247636761
-
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulinlike growth factor-I secretion
-
Tazzari PL, Tabellini G, Bortul R, et al. The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulinlike growth factor-I secretion. Leukemia. 2007;21: 886-896.
-
(2007)
Leukemia
, vol.21
, pp. 886-896
-
-
Tazzari, P.L.1
Tabellini, G.2
Bortul, R.3
-
56
-
-
34548138930
-
Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway
-
Doepfner KT, Spertini O, Arcaro A. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway. Leukemia. 2007;21:1921-1930.
-
(2007)
Leukemia
, vol.21
, pp. 1921-1930
-
-
Doepfner, K.T.1
Spertini, O.2
Arcaro, A.3
-
57
-
-
35148848549
-
Dual inhibition of PI3K/Akt signaling and the DNA damage checkpoint in p53-deficient cells with strong survival signaling: Implications for cancer therapy
-
Skladanowski A, Bozko P, Sabisz M, Larsen AK. Dual inhibition of PI3K/Akt signaling and the DNA damage checkpoint in p53-deficient cells with strong survival signaling: implications for cancer therapy. Cell Cycle. 2007;6:2268-2275.
-
(2007)
Cell Cycle
, vol.6
, pp. 2268-2275
-
-
Skladanowski, A.1
Bozko, P.2
Sabisz, M.3
Larsen, A.K.4
-
58
-
-
34247372619
-
MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS- 354/825
-
Nguyen TK, Rahmani M, Harada H, Dent P, Grant S. MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS- 354/825. Blood. 2007;109:4006-4015.
-
(2007)
Blood
, vol.109
, pp. 4006-4015
-
-
Nguyen, T.K.1
Rahmani, M.2
Harada, H.3
Dent, P.4
Grant, S.5
-
59
-
-
14944366978
-
PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas
-
Nakamura JL, Karlsson A, Arvold ND, et al. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas. J Neurooncol. 2005;71:215-222.
-
(2005)
J Neurooncol
, vol.71
, pp. 215-222
-
-
Nakamura, J.L.1
Karlsson, A.2
Arvold, N.D.3
-
60
-
-
33750459743
-
A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16
-
Billottet C, Grandage VL, Gale RE, et al. A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. Oncogene. 2006;25:6648-6659.
-
(2006)
Oncogene
, vol.25
, pp. 6648-6659
-
-
Billottet, C.1
Grandage, V.L.2
Gale, R.E.3
-
61
-
-
33744457653
-
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia
-
Martelli AM, Nyåkern M, Tabellini G, et al. Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia. 2006;20:911-928.
-
(2006)
Leukemia
, vol.20
, pp. 911-928
-
-
Martelli, A.M.1
Nyåkern, M.2
Tabellini, G.3
-
62
-
-
27144526660
-
-
Burchert A, Wang Y, Cai D, von Bubnoff N, et al. Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development. Leukemia. 200510:1774-1782.
-
Burchert A, Wang Y, Cai D, von Bubnoff N, et al. Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development. Leukemia. 200510:1774-1782.
-
-
-
-
63
-
-
17144387901
-
PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways
-
Grandage VL, Gale RE, Linch DC, Khwaja A. PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways. Leukemia. 2005;4:586-4594.
-
(2005)
Leukemia
, vol.4
, pp. 586-4594
-
-
Grandage, V.L.1
Gale, R.E.2
Linch, D.C.3
Khwaja, A.4
-
64
-
-
20844434173
-
Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance
-
Tseng PH, Lin HP, Zhu J, et al. Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance. Blood. 2005;105:4021-4027.
-
(2005)
Blood
, vol.105
, pp. 4021-4027
-
-
Tseng, P.H.1
Lin, H.P.2
Zhu, J.3
-
65
-
-
20444484563
-
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway
-
Bortul R, Tazzari PL, Billi AM, et al. Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway. Br J Haematol. 2005;129:677-686.
-
(2005)
Br J Haematol
, vol.129
, pp. 677-686
-
-
Bortul, R.1
Tazzari, P.L.2
Billi, A.M.3
-
66
-
-
34147190412
-
Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia
-
Román-Gómez J, Cordeu L, Agirre X, et al. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood. 2007;109: 3462-3469.
-
(2007)
Blood
, vol.109
, pp. 3462-3469
-
-
Román-Gómez, J.1
Cordeu, L.2
Agirre, X.3
|